Homewood, IL, United States of America

Kathleen M Cox


Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Homewood, IL (US) (1996)
  • Antelope, CA (US) (2010)
  • Bridgewater, NJ (US) (2010)
  • Katy, TX (US) (2019)

Company Filing History:


Years Active: 1996-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kathleen Cox: Pioneering Chemokine Receptor Inhibitors

Introduction

Kathleen Cox is an innovative inventor based in Bridgewater, NJ, known for her contributions to the field of pharmaceuticals. With a focus on developing novel compounds that act as inhibitors of chemokine receptors, her work is paving the way for advancements in treating various diseases.

Latest Patents

Kathleen holds a significant patent for "Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors." This invention introduces a new class of compounds that are structurally defined and have the potential to inhibit CCR5 receptors. These compounds play a crucial role in the treatment, prevention, and management of diseases associated with CCR5, such as Human Immunodeficiency Virus (HIV), solid organ transplant rejection, and various autoimmune conditions.

Career Highlights

Kathleen's career is marked by her commitment to innovation in the pharmaceutical industry. She has significantly contributed to the development of therapeutic solutions that target complex health issues. Currently, she is associated with the Schering Corporation, where she continues to work on ground-breaking inventions that positively impact patient care.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues such as Tze-Ming Chan and Wenqing Feng. These partnerships reflect her dedication to teamwork and advancing research in pharmaceuticals, demonstrating her ability to work effectively within diverse teams to push the boundaries of medical science.

Conclusion

Kathleen Cox exemplifies the spirit of innovation in drug development, particularly in the realm of chemokine receptors. Her patent for piperidinyl piperidine derivatives offers promising avenues for treating various health challenges, including HIV and autoimmune diseases. As she continues her work with Schering Corporation, her contributions are expected to advance the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…